Top Markets
#1 Zora Zora +38.60%
#2 Seeker Seeker +23.58%
#3 AI XOVIA AI XOVIA +23.13%
#4 Axelar Axelar +21.86%
#5 Full Moon Full Moon +18.72%
#6 0G 0G +16.10%
#7 Notcoin Notcoin +13.08%
#8 rsERG rsERG +10.68%
#9 VVS Finance VVS Finance +10.41%
#10 Cryptopia Cryptopia +10.26%
Coin of the day
Zora Zora
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Clasificación en acciones #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Precio por acción
$11.03
Última sincronización: 2026-08-28
Capitalización bursátil
$597.15M
Cambio (1 día)
-4.25%
Cambio (1 año)
-
País
US
Comercio Eikon Therapeutics, Inc. Common Stock (EIKN)

Categoría

Healthcare
Ratio P/S de Eikon Therapeutics, Inc. Common Stock (EIKN)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Eikon Therapeutics, Inc. Common Stock, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Eikon Therapeutics, Inc. Common Stock desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH